Lumos Pharma Inc reports results for the quarter ended in March - Earnings Summary

Lumos Pharma

10/05/2022 22:02

* Lumos Pharma Inc  LUMO.OQ  reported a quarterly adjusted
loss
of 92 cents​​ per share for the quarter ended in March. The mean
expectation of five analysts for the quarter was for a loss
of 89 cents per share.
    * Revenue was $111.00 thousand​;  analysts expected zero. 
    * Lumos Pharma Inc's reported EPS for the quarter was a loss
of 92
cents​.
    * The mean earnings estimate of analysts had risen by
about 8% in
the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Lumos Pharma Inc shares had fallen by 14.4% this
quarter and
gained 16.2% so far this year.
    * The company reported a quarterly loss of $7.72 million.
    * Wall Street's median 12-month price target for Lumos
Pharma Inc
is $25.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 10 at 09:01 p.m.  ​All
figures in US dollars unless otherwise stated